Bovi-Shield GOLD® FP® 5 L5 HB Now Available in 5-Dose Vial
Product line offers 5-way viral protection and prevents Lepto hardjo-bovis
NEW YORK — May 6, 2010 — Producers have a new vaccination management option with the introduction of a 5¬dose vial for Bovi-Shield GOLD® FP® 5 L5 HB. Pfizer Animal Health now offers the vaccine in convenient 5-, 10- and 50-dose vials.
Bovi-Shield GOLD FP 5 L5 HB helps provide superior protection against five major viral pathogens: IBR, PI3, BRSV, and BVD Types 1 and 2, and prevents Lepto hardjo-bovis.*
“It is important for each producer to work with his or her veterinarian to develop an individualized vaccination program that protects cattle from Lepto hardjo-bovis and other important reproductive diseases,” says Glenn Rogers, DVM, MS, DABVP, Veterinary Operations, Pfizer Animal Health. “The new 5-dose option gives producers expanded flexibility within their vaccination programs.”
Bovi-Shield GOLD FP 5 L5 HB offers an unmatched duration of immunity, with at least 365 days of protection from IBR abortions; BVD Types 1 and 2 persistent infection; and Lepto hardjo-bovis infection, urinary shedding and kidney colonization. It also offers producers convenience and flexibility since it can be administered either intramuscularly or subcutaneously.
Lepto hardjo-bovis is the most prevalent strain of Leptospira in U.S. cow herds. A study found 42 percent of beef herds were infected.1 What’s more, a previously reported study also suggested 59 percent of U.S. dairy herds may be infected with Leptospira.2 In both beef and dairy cattle, this disease may cause poor reproductive performance, early embryonic death, delayed breeding, abortions, weak or stillborn calves, and unexplained infertility.
“Without an effective vaccination program in place, Lepto hardjo-bovis can be a destructive problem that can go undetected and harm a herd’s reproductive health and efficiency,” Dr. Rogers adds. “That’s why producers should implement a vaccination protocol that not only prevents Lepto hardjo-bovis and helps protect an operation’s reproductive investment, but also is convenient and fits the needs of their specific operations. The addition of a 5¬dose vial option for Bovi-Shield GOLD FP 5 L5 HB provides just that.”
For more information on Bovi-Shield GOLD FP 5 L5 HB, producers should contact their local veterinarian, animal health supplier or Pfizer Animal Health representative.
Pfizer Animal Health, a business of Pfizer Inc., is a world leader in discovering and developing innovative animal prescription medicines and vaccines, investing an estimated $300 million annually. Beyond the U.S., Pfizer Animal Health also supports veterinarians and their customers in more than 60 countries around the world. For more information on how Pfizer Animal Health works to ensure a safe, sustainable global food supply with healthy livestock and poultry, or how Pfizer helps companion animals and horses to live longer, healthier lives, visit www.pfizerah.com.
Product Photo Cutline: The introduction of a 5-dose vial of Bovi-Shield GOLD® FP® 5 L5 HB provides producers with a new vaccination management option. Pfizer Animal Health now offers the vaccine in 5-, 10- and 50-dose vials.
1. Wikse SE, Rogers GM, et al. Herd prevalence and risk factors of Leptospira infection in beef cow/calf operations in the United States: Leptospira borgpetersenii serovar hardjo. The Bovine Practitioner 2007;41(1):15-23.
2. Bolin CA. Bovine leptospirosis prevalent in U.S. dairy herds. Bov Vet Feb. 14-15, 2003.
*LABEL INDICATIONS: The Bovi-Shield GOLD line and PregGuard® GOLD FP® 10 are recommended for vaccination of healthy cows and heifers approximately 1 month prior to breeding. These products can also be administered to pregnant cattle provided they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP or PregGuard GOLD FP vaccine prior to breeding initially and within 12 months thereafter. Failure to
follow label directions may result in abortions. The Bovi-Shield GOLD line may be administered to calves nursing pregnant cows, provided their dams were vaccinated within the last 12 months as described above. Consistent with good vaccination practices, heifers should receive at least two vaccine doses, with the second dose administered approximately 30 days pre-breeding.
All brands are the property of Pfizer Inc., its affiliates and/or its licensors. ©2010 Pfizer Inc. All rights reserved.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States